Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors

Author(s): Somayeh Hashemi Sheikhshabani, Zeinab Amini-Farsani, Nesa Kazemifard, Parastoo Modarres, Sharareh Khazaei Feyzabad, Zahra Amini-Farsani, Nasibeh Shaygan, Mir Davood Omrani and Soudeh Ghafouri-Fard*

Volume 29, Issue 24, 2023

Published on: 28 August, 2023

Page: [1907 - 1917] Pages: 11

DOI: 10.2174/1381612829666230816105221

Price: $65

Abstract

Purpose: Acute kidney injury (AKI) accounts for up to 29% of severe COVID-19 cases and increases mortality among these patients. Viral infections participate in the pathogenesis of diseases by changing the expression profile of normal transcriptome. This study attempts to identify LncRNA-miRNA-gene and TF-gene networks as gene expression regulating networks in the kidney tissues of COVID-19 patients.

Methods: In this analysis, four kidney libraries from the GEO repository were considered. To conduct the preprocessing, Deseq2 software in R was used for the purpose of data normalization and log2 transformation. In addition, pre- and post-normalization, PCA and box plots were developed using ggplot2 software in R for quality control. The expression profiles of the kidney samples of COVID-19 patients and control individuals were compared using DEseq2 software in R. The considered significance thresholds for DEGs were Adj P value < 0.05 and |logFC| >2. Then, to predict molecular interactions in lncRNA-miRNA-gene networks, different databases, including DeepBase v3.0, miRNATissueAtlas2, DIANA-LncBase v3, and miRWalk, were used. Furthermore, by employing ChEA databases, interactions at the TF-Gene level were obtained. Finally, the obtained networks were plotted using Stringdb and Cytoscape v8.

Results: Results obtained from the comparison of the post-mortem kidney tissue samples of the COVID-19 patients with the healthy kidney tissue samples showed significant changes in the expression of more than 2000 genes. In addition, predictions regarding the miRNA-gene interaction network based on DEGs obtained from this meta-analysis showed that 11 miRNAs targeted the obtained DEGs. Interestingly, in the kidney tissue, these 11 miRNAs interacted with LINC01874, LINC01788, and LINC01320, which have high specificity for this tissue. Moreover, four transcription factors of EGR1, SMAD4, STAT3, and CHD1 were identified as key transcription factors regulating DEGs. Taken together, the current study showed several dysregulated genes in the kidney of patients affected with COVID-19.

Conclusion: This study suggests lncRNA-miRNA-gene networks and key TFs as new diagnostic and therapeutic targets for experimental and preclinical studies.

« Previous Next »
[1]
Chua RL, Lukassen S, Trump S, et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat Biotechnol 2020; 38(8): 970-9.
[http://dx.doi.org/10.1038/s41587-020-0602-4] [PMID: 32591762]
[2]
Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol 2020; 51(6): 613-28.
[http://dx.doi.org/10.1007/s10735-020-09915-3] [PMID: 33011887]
[3]
Paidas MJ, Sampath N, Schindler EA, et al. Mechanism of multi-organ injury in experimental COVID-19 and its inhibition by a small molecule peptide. Front Pharmacol 2022; 13: 864798.
[http://dx.doi.org/10.3389/fphar.2022.864798] [PMID: 35712703]
[4]
Murashima M, Nishimoto M, Kokubu M, et al. Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep 2019; 9(1): 20260.
[http://dx.doi.org/10.1038/s41598-019-56615-4] [PMID: 31889082]
[5]
Medeiros T, Guimarães GMC, Carvalho FR, et al. Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators. Cytokine 2022; 157: 155974.
[http://dx.doi.org/10.1016/j.cyto.2022.155974] [PMID: 35907365]
[6]
Haftcheshmeh SM, Abedi M, Mashayekhi K, et al. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-κB, JAK/STAT, and MAPK signaling pathways. Phytother Res 2022; 36(3): 1216-30.
[http://dx.doi.org/10.1002/ptr.7407] [PMID: 35142403]
[7]
Tucker AR, Salazar NA, Ayoola AO, Memili E, Thomas BN, Morenikeji OB. Regulatory network of miRNA, lncRNA, transcription factor and target immune response genes in bovine mastitis. Sci Rep 2021; 11(1): 21899.
[http://dx.doi.org/10.1038/s41598-021-01280-9] [PMID: 34753991]
[8]
Wu Y, Gui Y, Wu D, Wu Q. Construction and analysis of mRNA and lncRNA regulatory networks reveal the key genes associated with prostate cancer related fatigue during localized radiation therapy. Curr Bioinform 2021; 16(2): 230-9.
[http://dx.doi.org/10.2174/1574893615999200901105208]
[9]
Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci STKE 2007; 2007(367): re1-1.
[http://dx.doi.org/10.1126/stke.3672007re1] [PMID: 17200520]
[10]
López-Urrutia E, Montes BLP, Ladrón de Guevara Cervantes D, Pérez-Plasencia C, Campos-Parra AD. Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: Deciphering molecular mechanisms of master regulators in cancer. Front Oncol 2019; 9: 669.
[http://dx.doi.org/10.3389/fonc.2019.00669] [PMID: 31404273]
[11]
Gao L, Zhao Y, Ma X, Zhang L. Integrated analysis of lncRNA–miRNA–mRNA ceRNA network and the potential prognosis indicators in sarcomas. BMC Med Genomics 2021; 14(1): 67.
[http://dx.doi.org/10.1186/s12920-021-00918-x] [PMID: 33653335]
[12]
Chen L, Zhou Y, Li H. LncRNA, miRNA and lncRNA-miRNA interaction in viral infection. Virus Res 2018; 257: 25-32.
[http://dx.doi.org/10.1016/j.virusres.2018.08.018] [PMID: 30165080]
[13]
Casamassimi A, Federico A, Rienzo M, Esposito S, Ciccodicola A. Transcriptome profiling in human diseases: New advances and perspectives. Int J Mol Sci 2017; 18(8): 1652.
[http://dx.doi.org/10.3390/ijms18081652] [PMID: 28758927]
[14]
Xie X, Zhang Y, Yu J, Jiang F, Wu C. Significance of m6A regulatory factor in gene expression and immune function of osteoarthritis. Front Physiol 2022; 13: 918270.
[http://dx.doi.org/10.3389/fphys.2022.918270] [PMID: 36160850]
[15]
Goutsias J, Lee N. Computational and experimental approaches for modeling gene regulatory networks. Curr Pharm Des 2007; 13(14): 1415-36.
[http://dx.doi.org/10.2174/138161207780765945] [PMID: 17504165]
[16]
Abbaszadeh O, Khanteymoori AR, Azarpeyvand A. Parallel algorithms for inferring gene regulatory networks: A review. Curr Genomics 2018; 19(7): 603-14.
[http://dx.doi.org/10.2174/1389202919666180601081718] [PMID: 30386172]
[17]
Emmert-Streib F, Dehmer M, Haibe-Kains B. Gene regulatory networks and their applications: Understanding biological and medical problems in terms of networks. Front Cell Dev Biol 2014; 2: 38.
[http://dx.doi.org/10.3389/fcell.2014.00038] [PMID: 25364745]
[18]
Sheikhshabani SH, Amini-Farsani Z, Modarres P, et al. In silico identification of potential miRNAs-mRNA inflammatory networks implicated in the pathogenesis of COVID-19. Hum Genet 2023; 36: 201172.
[19]
Sabaghian T, Kharazmi AB, Ansari A, et al. COVID-19 and acute kidney injury: A systematic review. Front Med 2022; 9: 705908.
[http://dx.doi.org/10.3389/fmed.2022.705908] [PMID: 35445048]
[20]
Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics challenges and potential solutions. Nat Rev Drug Discov 2021; 20(8): 629-51.
[http://dx.doi.org/10.1038/s41573-021-00219-z] [PMID: 34145432]
[21]
Huang SF, Peng XF, Jiang L, Hu CY, Ye WC. LncRNAs as therapeutic targets and potential biomarkers for lipid-related diseases. Front Pharmacol 2021; 12: 729745.
[http://dx.doi.org/10.3389/fphar.2021.729745] [PMID: 34421622]
[22]
Liu W, Ding C. Roles of lncRNAs in viral infections. Front Cell Infect Microbiol 2017; 7: 205.
[http://dx.doi.org/10.3389/fcimb.2017.00205] [PMID: 28603696]
[23]
Liu Z, Dai W, Wang S, Yao Y, Zhang H. Deep learning identified genetic variants associated with COVID-19 related mortality medRxiv 2022.
[http://dx.doi.org/10.1101/2022.05.05.22274731]
[24]
Garnier N, Pollet K, Fourcot M, et al. Altered microRNA expression in severe COVID-19: potential prognostic and pathophysiological role medRxiv 2022.
[25]
Pierce JB, Simion V, Icli B, Pérez-Cremades D, Cheng HS, Feinberg MW. Computational analysis of targeting SARS-CoV-2, viral entry proteins ACE2 and TMPRSS2, and interferon genes by host microRNAs. Genes 2020; 11(11): 1354.
[http://dx.doi.org/10.3390/genes11111354] [PMID: 33207533]
[26]
Liu J, Li Y, Lyu L, et al. Integrin α5 Is regulated by miR-218-5p in endothelial progenitor cells. J Am Soc Nephrol 2022; 33(3): 565-82.
[http://dx.doi.org/10.1681/ASN.2021020140] [PMID: 35091451]
[27]
Ding G, an J, Li L. MicroRNA-103a-3p enhances sepsis-induced acute kidney injury via targeting CXCL12. Bioengineered 2022; 13(4): 10288-98.
[http://dx.doi.org/10.1080/21655979.2022.2062195] [PMID: 35510354]
[28]
Samy A, Maher MA, Abdelsalam NA, Badr E. SARS-CoV-2 potential drugs, drug targets, and biomarkers: A viral-host interaction network-based analysis. Sci Rep 2022; 12(1): 11934.
[http://dx.doi.org/10.1038/s41598-022-15898-w] [PMID: 35831333]
[29]
Fu Y, Wang C, Zhang D, Chu X, Zhang Y, Li J. miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A. J Cell Physiol 2019; 234(11): 20869-78.
[http://dx.doi.org/10.1002/jcp.28691] [PMID: 31025335]
[30]
Nersisyan S, Engibaryan N, Gorbonos A, Kirdey K, Makhonin A, Tonevitsky A. Potential role of cellular miRNAs in coronavirus-host interplay. PeerJ 2020; 8: e9994.
[http://dx.doi.org/10.7717/peerj.9994] [PMID: 32983652]
[31]
Fernández-Pato A, Virseda-Berdices A, Resino S, et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg Microbes Infect 2022; 11(1): 676-88.
[http://dx.doi.org/10.1080/22221751.2022.2038021] [PMID: 35130828]
[32]
Eyileten C, Wicik Z, Simões SN, et al. Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. RNA Biol 2022; 19(1): 963-79.
[http://dx.doi.org/10.1080/15476286.2022.2100629] [PMID: 35938548]
[33]
David de, G-C, Benítez ID, Pinilla L, et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl Res 2021; 236: 147-59.
[http://dx.doi.org/10.1016/j.trsl.2021.05.004] [PMID: 34048985]
[34]
Fayyad-Kazan M, Makki R, Skafi N, et al. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect Genet Evol 2021; 94: 105020.
[http://dx.doi.org/10.1016/j.meegid.2021.105020] [PMID: 34343725]
[35]
Wilson JC, Kealy D, James SR, et al. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19. iScience 2022; 25(1): 103672.
[http://dx.doi.org/10.1016/j.isci.2021.103672] [PMID: 34957382]
[36]
Wang Y, Li J, Zhang L, et al. Plasma cell-free RNA characteristics in COVID-19 patients. Genome Res 2022; 32(2): 228-41.
[http://dx.doi.org/10.1101/gr.276175.121] [PMID: 35064006]
[37]
Ament SA, Pearl JR, Cantle JP, et al. Transcriptional regulatory networks underlying gene expression changes in Huntington’s disease. Mol Syst Biol 2018; 14(3): e7435.
[http://dx.doi.org/10.15252/msb.20167435] [PMID: 29581148]
[38]
Gamart J, Barozzi I, Laurent F, et al. SMAD4 target genes are part of a transcriptional network that integrates the response to BMP and SHH signaling during early limb bud patterning. Development 2021; 148(23): dev200182.
[http://dx.doi.org/10.1242/dev.200182] [PMID: 34822715]
[39]
Kennedy BA, Deatherage DE, Gu F, et al. ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: Implications with clinical outcome of ovarian cancer. PLoS One 2011; 6(7): e22606.
[http://dx.doi.org/10.1371/journal.pone.0022606] [PMID: 21799915]
[40]
Robinson RL, Sharma A, Bai S, et al. Comparative STAT3-regulated gene expression profile in renal cell carcinoma subtypes. Front Oncol 2019; 9: 72.
[http://dx.doi.org/10.3389/fonc.2019.00072] [PMID: 30863721]
[41]
Ramana CV, Das B. Regulation of early growth response-1 (Egr-1) gene expression by Stat1-independent type I interferon signaling and respiratory viruses. Comput Math Biophys 2021; 9(1): 289-303.
[http://dx.doi.org/10.1515/cmb-2020-0129]
[42]
Li SW, Wang CY, Jou YJ, et al. SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway. Sci Rep 2016; 6(1): 25754.
[http://dx.doi.org/10.1038/srep25754] [PMID: 27173006]
[43]
Carlson FR Jr, Bosukonda D, Keck PC, Carlson WD. Multiorgan damage in patients with COVID-19: Is the TGF-β/BMP pathway the missing link? JACC Basic Transl Sci 2020; 5(11): 1145-8.
[http://dx.doi.org/10.1016/j.jacbts.2020.09.003] [PMID: 32984657]
[44]
Chetta M, Rosati A, Marzullo L, Tarsitano M, Bukvic N. A SARS-CoV-2 host infection model network based on genomic human transcription factors (TFs) depletion. Heliyon 2020; 6(10): e05010.
[http://dx.doi.org/10.1016/j.heliyon.2020.e05010] [PMID: 32984567]
[45]
Marcos-Villar L, Pazo A, Nieto A. Influenza virus and chromatin: Role of the CHD1 chromatin remodeler in the virus life cycle. J Virol 2016; 90(7): 3694-707.
[http://dx.doi.org/10.1128/JVI.00053-16] [PMID: 26792750]
[46]
Jit BP, Qazi S, Arya R, Srivastava A, Gupta N, Sharma A. An immune epigenetic insight to COVID-19 infection. Epigenomics 2021; 13(6): 465-80.
[http://dx.doi.org/10.2217/epi-2020-0349] [PMID: 33685230]
[47]
Tong H, Chen H, Williams CM. Identification of transcription factors regulating SARS-CoV-2 tropism factor expression by inferring cell-type-specific transcriptional regulatory networks in human lungs. Viruses 2022; 14(4): 837.
[http://dx.doi.org/10.3390/v14040837] [PMID: 35458567]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy